CHIARA S.
- Country
- Italy
- Department
- Neurologia-Stroke Unit
Research Overview
- A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
- Tranexamic acid for hyperacute spontaneous IntraCerebral Haemorrhage (TICH-3)
Data & Insights
Has run more than one trial at 20 of 295 partner sites.
Specializations
Cerebrovascular Disorders
This investigator specializes in treating various forms of stroke and cerebrovascular conditions, with particular emphasis on acute interventions and management strategies.
- Intracerebral Hemorrhage Management
- Acute Ischemic Stroke Treatment
- Transient Ischemic Attack Prevention
The investigator focuses on evaluating innovative therapeutic approaches for patients experiencing acute cerebrovascular events.
Emergency Neurology
The investigator's work centers on hyperacute neurological interventions, particularly in the critical early hours following stroke onset.
- Early Stroke Intervention
- Emergency Neurological Care
- Acute Stroke Management
Their expertise extends to emergency protocols for various types of stroke presentations and rapid therapeutic responses.
Preventive Neurology
The investigator works on stroke prevention strategies and interventions to reduce recurrent cerebrovascular events.
- Secondary Stroke Prevention
- Risk Factor Management
- Preventive Therapeutics
Their focus includes developing strategies to minimize stroke recurrence in high-risk patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.